Federation des caisses Desjardins du Quebec’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,800	Closed	-$52K	–	2234
2020 Q2	$52K	Buy	5,800 +4,600	+383%	+$42.7K	﹤0.01%	1201
2020 Q1	$7.64K	Hold	1,200	–	–	﹤0.01%	1719
2019 Q4	$10K	Hold	1,200	–	–	﹤0.01%	1886
2019 Q3	$10.9K	Hold	1,200	–	–	﹤0.01%	1798
2019 Q2	$12.9K	Hold	1,200	–	–	﹤0.01%	1790
2019 Q1	$11.4K	Hold	1,200	–	–	﹤0.01%	1642
2018 Q4	$13.8K	Hold	1,200	–	–	﹤0.01%	1558
2018 Q3	$20.3K	Buy	+1,200	New	+$18.2K	﹤0.01%	1556

Other funds holding SGMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's SGMO Position: Q3 2020 in Review

Federation des caisses Desjardins du Quebec sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2020, closing a stake of 5,800 shares — an estimated $52K sold.

Federation des caisses Desjardins du Quebec first reported a position in SGMO in Q3 2018 and held it in 8 quarters. The position peaked at $52K in Q2 2020. 210 funds tracked by Wall St. Rank hold SGMO as of Q3 2020.

Federation des caisses Desjardins du Quebec reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2020 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 5,800 SANGAMO THERAPEUTICS INC shares in Q3 2020, an estimated $52K.
Federation des caisses Desjardins du Quebec first reported a position in SANGAMO THERAPEUTICS INC in Q3 2018 and held it in 8 quarters.
Federation des caisses Desjardins du Quebec's SANGAMO THERAPEUTICS INC position peaked at $52K in Q2 2020.
210 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2020.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2020, filed 30 Aug 2024.